As of February 2026 ArriVent BioPharma has a market cap of โน87.42 Billion. This makes ArriVent BioPharma the world's 6109th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Feb 25th, 2026 the market cap of ArriVent BioPharma was reported to be: